Concepedia

Publication | Open Access

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study

DOIFull Paper Access

21

Citations

27

References

2014

Year

Caroline Barau, Joséphine Braun, Corine Vincent, Stéphanie Haïm‐Boukobza, Jean‐Michel Molina, Patrick Miailhes, Isabelle Fournier, J Aboulker, Daniel Vittecoq, Jean‐Charles Duclos‐Vallée,
Clinical Infectious Diseases

Abstract

The results of the substudy 1 support RAL administration to patients with ESLD. Substudy 2 assesses the safety, tolerability, and efficacy of RAL therapy in HIV-infected patients after liver transplant. RAL might be recommended as a suitable antiretroviral therapy in HIV-infected patients undergoing liver transplant.

References

YearCitations

Page 1